ENTRY       D10948                      Drug
NAME        Larcaviximab (USAN/INN);
            ZMapp (TN)
SEQUENCE    (Heavy chain)
            EVQLQESGPE LEMPGASVKI SCKASGSSFT GFSMNWVKQS NGKSLEWIGN IDTYYGGTTY
            NQKFKGKATL TVDKSSSTAY MQLKSLTSED SAVYYCARSA YYGSTFAYWG QGTLVTVSAA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            DIQMTQSPAS LSASVGETVT ITCRASENIY SYLAWYQQKQ GKSPQLLVYN AKTLIEGVPS
            RFSGSGSGTQ FSLKINSLQP EDFGSYFCQH HFGTPFTFGS GTELEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV 1DNALQSGNSQ ESVTEQDSKD
            STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, 369-H427, H'22-H96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of Ebola virus disease
TARGET      Ebolavirus envelope glycoprotein [KO:K24534]
  PATHWAY   ko03230(K24534)  Viral genome structure
BRITE       Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Ebolavirus glycoprotein
                D10948  Larcaviximab (USAN/INN)
DBLINKS     CAS: 1792982-56-9
            PubChem: 350078325
///
